Paradoxical effect of levetiracetam on seizure suppression: Three cases showing U curve association between dose and effect

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

We experienced 3 adult patients with intractable focal epilepsy treated by levetiracetam (LEV) as polytherapy, who showed paradoxical effect (PE). Starting dose of LEV was small (62.5, 250 mg/day) and we gradually increased by less than 250 mg/day, every more than 2 weeks. Within 6 months after LEV was added, LEV of 750 to 1,000 mg/day brought reduction of seizure frequency. Serum concentration of LEV was 13.3 and 14.0 μg/ml. In order to obtain better seizure control, LEV was increased up to 1,000–2,500 mg/day (19.3–35.0 μg/ml) within one year, and they developed PE. They all showed increased habitual seizures, occurring in cluster. Once dose of LEV deceased down to what produced the maximum seizure suppression, all of the patients regained the better seizure control. It is most likely that at least in some patients like present 3 cases, PE of LEV may express U curve association between dose and effect and that it was only delineated by slow titration.

Cite

CITATION STYLE

APA

Inoue, T., Kobayashi, K., Usami, K., Shimotake, A., Inouchi, M., Sakai, T., … Takahashi, R. (2021). Paradoxical effect of levetiracetam on seizure suppression: Three cases showing U curve association between dose and effect. Clinical Neurology, 61(4), 247–252. https://doi.org/10.5692/clinicalneurol.cn-001553

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free